Is NewAmsterdam Pharma Company N.V. (NAMS) a Buy, Sell, or Hold?
NASDAQ : NAMS
NewAmsterdam Pharma Company N.V. — Competitors
$27.79 USD
-$0.67 (-2.35%)
- Volume
- 952.3K
- Average Volume
- 1.3M
- Market Capitalization
- $3.25B
- P/E Ratio
- -15.35
- Dividend Yield
- 0.00%
- Price Target
- $48.00
- Year High
- $42.21
- Year Low
- $21.23
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.76
NAMS vs. The Competition
| Properties | NAMS | ACLX | AKRO | CGON |
|---|---|---|---|---|
| Market Cap | $3.25B | $6.73B | $4.5B | $6.28B |
| Shares Outstanding | $116.9M | $58.51M | $82.32M | $88.2M |
| P/E Ratio | -15.35 | -28.27 | -19.87 | -30.42 |
| EPS | -1.76 | -4.07 | -2.72 | -2.21 |
| Day Low | 27.31 | 115.03 | 54.52 | 69.602 |
| Day High | 28.76 | 115.07 | 54.65 | 72.94 |
| Year Low | 21.234 | 50.85 | 21.34 | 23.65 |
| Year High | 42.205 | 115.13 | 58.4 | 77 |
| Average Price 50 | 32.2922 | 112.6244 | 53.0613 | 66.0188 |
| Average Price 200 | 33.85065 | 84.1487 | 48.19307 | 56.793 |
| Volume | 952.3K | 13.19M | 11.61M | 560.78K |
| Average Volume | - | - | - | - |